Reproductive tech: Screening and Testing Flashcards
Define screening test, in the context of pregnancy.
- Offered to all pregnant women to assess the chance of you or your baby having a particular health problem or disability.
- Usually simple tests (for example, a blood test, ultrasound scan or questionnaire).
- Do NOT provide a definite diagnosis, but help you and your midwife decide whether you need further tests to make that diagnosis
Define diagnostic test, in the context of pregnancy.
- Follow-on tests that we carry out to find out whether your baby does have a particular condition.
- Offered to women who have had a ‘higher-chance’ result from screening.
- May involve chorionic villus sampling or amniocentesis, which can be associated with a slightly increased risk of miscarriage. Alternatively it may involve a detailed ultrasound scan.
Identify possible reasons to carry out screening/testing.
- To reassure parents (but not straightforward…)
- To inform and prepare parents for the birth of an affected infant;
a) Decision on timing, mode and place of delivery
b) Preparing parents to cope with an affected child
c) Introducing parents to specialist neonatal services
d) Ensuring foetal surveillance - To allow in utero treatment,
- To allow termination of an affected fetus
- To provide information so that parents may choose between 2, 3 or 4 (key issue here = choice)
Identify the main screening tests performed on pregnant women.
(for natural conception)
-Non-invasive screening, e.g. ultrasound, serum test (both of them used together in Down’s Syndrome screening)
Identify the main diagnostic tests performed on pregnant women.
(for natural conception)
- Invasive prenatal diagnostic (PND) testing, e.g. chorionic villus sampling, amniocentesis
- Non-invasive prenatal genetic testing (NIPT)
(for IVF) (extra testing)
-Preimplantation genetic diagnosis (PGD)
What is US ?
Uses sound waves; painless; no risk
When and why may we use ultrasound as a screening technique in pregnancy ?
When is it? Two screenings offered:
1) Dating scan: 12 weeks (8 – 14)- get gestational age + viability of the pregnancy
2) Anomaly scan: 20 weeks (18 – 20 weeks and 6 days)- look for structural abnormalities
Why is it?
Anomaly: physical abnormalities, e.g. spina bifida
Identify ethical abnormalities arising from US screening.
Everyone is offered anomaly scan, not everyone chooses to take it
Describe the screening test for Down’s Syndrome.
♦ Combined screening test, combination of ultrasound and serum test, at 10 – 13+6 weeks (measures the chance of DS, NOT a diagnostic test (note: can also detect other trisomies))
♦ US component: Nuchal translucency (increased translucence if cardiac abnormalities, and in certain trisomies)
Serum component: Analyse markers in blood, including: pregnancy associated plasma protein-A (PAPP-A), decreased in Down’s; free ß-human chorionic gonadotrophin (free ß-hCG), increased in Down’s
Identify any ethical issues arising from screening test of Down’s Syndrome.
Risk (low v high); if greater than 1:150 then option to take diagnostic test (amniocentesis or CVS).
Down’s Syndrome
- Other names
- Cause
- proportion with congenital abnormality
- proportion with severe intellectual impairment
- prevalence
- Trisomy 21
- Usually due to non- disjunction at chromosome 21 at meiosis
- 50 % will have a congenital abnormality
- 80% profound or severe intellectual impairment
- Natural prevalence 1:600 live births but incidence now 6:10,000 (because often decide to terminate pregnancy)
Describe the correlation between maternal age and risk of Down’s Syndrome.
25: 1 in 1500
30: 1 in 1000
40: 1 in 100
How specific and sensitive is the combined screening test for DS ?
• False positives (i.e. test indicates DS, but fetus not affected)
2.2%
• False negatives (related to “detection rate”, i.e. test does not indicated DS, but fetus affected)
16%
Which screening test is used for DN if the mother presents later than 14 weeks ?
QUADRUPLE TEST
- Used if women presents later (14 weeks 2 days +)
- Blood test: alpha-fetoprotein (AFP) (decreased in DS); total human chorionic gonadotrophin (hCG) (increased in DS); unconjugated oestriol (decreased in DS); inhibin-A (increased in DS)
- No Ultrasound
- If high risk, may offer diagnostic test
How specific and sensitive is the quadruple test for DS ?
FP: 3.5%
FN: 20%